Literature DB >> 10554771

Expression and secretion of proteins in E. coli.

O Pines1, M Inouye.   

Abstract

This review outlines approaches to the cloning and expression of proteins in Escherichia coli. The expression vectors described here (pIN-III derivatives) utilize the strong lipoprotein promoter, which is controlled by the lac-UV5 promoter-operator. These vectors provide the means for targeting a protein to any of the four subcellular compartments of the bacterial cell: cytoplasm, cytoplasmic membrane, periplasm, and outer membrane. Of particular importance is that secretion of proteins into the E. coli periplasm (using the OmpA signal peptide) is applicable for the production of both prokaryotic and eukaryotic proteins thereby enhancing protein activity and stability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554771     DOI: 10.1385/MB:12:1:25

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  24 in total

Review 1.  Protein secretion in bacteria.

Authors:  J M Gennity; M Inouye
Journal:  Curr Opin Biotechnol       Date:  1991-10       Impact factor: 9.740

2.  Recombinant gene expression protocols. Overview of experimental strategies for the expression of recombinant genes.

Authors:  R S Tuan
Journal:  Methods Mol Biol       Date:  1997

3.  Secretion cloning vectors for guiding the localization of proteins in vivo.

Authors:  C A Lunn; M Takahara; M Inouye
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  Overproduction of fungal ribotoxin alpha-sarcin in Escherichia coli: generation of an active immunotoxin.

Authors:  D Rathore; S K Nayak; J K Batra
Journal:  Gene       Date:  1997-04-29       Impact factor: 3.688

5.  A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.

Authors:  M P Pritchard; R Ossetian; D N Li; C J Henderson; B Burchell; C R Wolf; T Friedberg
Journal:  Arch Biochem Biophys       Date:  1997-09-15       Impact factor: 4.013

6.  Mechanism of localization of major outer membrane lipoprotein in Escherichia coli. Studies with the OmpF-lipoprotein hybrid protein.

Authors:  F Yu; H Furukawa; K Nakamura; S Mizushima
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  A single chain Fv fragment of P-glycoprotein-specific monoclonal antibody C219. Design, expression, and crystal structure at 2.4 A resolution.

Authors:  F J Hoedemaeker; T Signorelli; K Johns; D A Kuntz; D R Rose
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

Review 8.  Signal peptide mutants of Escherichia coli.

Authors:  J Gennity; J Goldstein; M Inouye
Journal:  J Bioenerg Biomembr       Date:  1990-06       Impact factor: 2.945

9.  Construction and characterization of a set of E. coli strains deficient in all known loci affecting the proteolytic stability of secreted recombinant proteins.

Authors:  H J Meerman; G Georgiou
Journal:  Biotechnology (N Y)       Date:  1994-11

10.  Secretion cloning vectors in Escherichia coli.

Authors:  J Ghrayeb; H Kimura; M Takahara; H Hsiung; Y Masui; M Inouye
Journal:  EMBO J       Date:  1984-10       Impact factor: 11.598

View more
  11 in total

1.  Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli.

Authors:  H Sletta; A Nedal; T E V Aune; H Hellebust; S Hakvåg; R Aune; T E Ellingsen; S Valla; T Brautaset
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

2.  Collagen binding by the mannose receptor mediated through the fibronectin type II domain.

Authors:  Catherine E Napper; Kurt Drickamer; Maureen E Taylor
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

3.  Studies of single-chain antibody expression in quiescent Escherichia coli.

Authors:  K J Mukherjee; D C D Rowe; N A Watkins; D K Summers
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

4.  Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis.

Authors:  Keehwan Kwon; Jeremy Hasseman; Saeeda Latham; Carissa Grose; Yu Do; Robert D Fleischmann; Rembert Pieper; Scott N Peterson
Journal:  BMC Biochem       Date:  2011-05-05       Impact factor: 4.059

5.  Optimization of expression and purification of HSPA6 protein from Camelus dromedarius in E. coli.

Authors:  Ajamaluddin Malik; Abdulrahman M Alsenaidy; Mohamed Elrobh; Wajahatullah Khan; Mohammed S Alanazi; Mohammad D Bazzi
Journal:  Saudi J Biol Sci       Date:  2015-05-04       Impact factor: 4.219

Review 6.  Protein fusion tags for efficient expression and purification of recombinant proteins in the periplasmic space of E. coli.

Authors:  Ajamaluddin Malik
Journal:  3 Biotech       Date:  2016-02-04       Impact factor: 2.406

7.  Novel prokaryotic expression of thioredoxin-fused insulinoma associated protein tyrosine phosphatase 2 (IA-2), its characterization and immunodiagnostic application.

Authors:  Luciano Lucas Guerra; Natalia Inés Faccinetti; Aldana Trabucchi; Bruno David Rovitto; Adriana Victoria Sabljic; Edgardo Poskus; Ruben Francisco Iacono; Silvina Noemí Valdez
Journal:  BMC Biotechnol       Date:  2016-11-24       Impact factor: 2.563

8.  Prokaryotic expression and characterization of the heterodimeric construction of ZnT8 and its application for autoantibodies detection in diabetes mellitus.

Authors:  Natalia I Faccinetti; Luciano L Guerra; Adriana V Sabljic; Silvina S Bombicino; Bruno D Rovitto; Ruben F Iacono; Edgardo Poskus; Aldana Trabucchi; Silvina N Valdez
Journal:  Microb Cell Fact       Date:  2017-11-13       Impact factor: 5.328

Review 9.  Toxins from cone snails: properties, applications and biotechnological production.

Authors:  Stefan Becker; Heinrich Terlau
Journal:  Appl Microbiol Biotechnol       Date:  2008-03-14       Impact factor: 4.813

10.  Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors.

Authors:  E A Sokolova; O A Stremovskiy; T A Zdobnova; I V Balalaeva; S M Deyev
Journal:  Acta Naturae       Date:  2015 Oct-Dec       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.